---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-24-000074"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:23:33.803047+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Avanos Medical reports Q2 2024 results; filing lacks detailed financials

## Summary
- Results announced for three and six months ended June 30, 2024.
- No specific revenue, EPS, or segment figures available in provided text.
- Guidance or outlook not mentioned in the filing excerpt.

## SEC filing metadata
- accession: 0001606498-24-000074
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000074/0001606498-24-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000074/avns-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-24-000074
- JSON: https://secwatch.observer/filing/0001606498-24-000074.json
- Plain text: https://secwatch.observer/filing/0001606498-24-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.